Extended Evaluation of Virological, Immunological and Pharmacokinetic Endpoints of CELADEN: A Randomized, Placebo-Controlled Trial of Celgosivir in Dengue Fever Patients

Extended Evaluation of Virological, Immunological and Pharmacokinetic Endpoints of CELADEN: A Randomized, Placebo-Controlled Trial of Celgosivir in Dengue Fever Patients

10.1371/journal.pntd.0004851

Saved in:
Bibliographic Details
Main Authors: Sung C., Wei Y., Watanabe S., Lee H.S., Khoo Y.M., Fan L., Rathore A.P.S., Chan K.W.-K., Choy M.M., Kamaraj U.S., Sessions O.M., Aw P., de Sessions P.F., Lee B., Connolly J.E., Hibberd M.L., Vijaykrishna D., Wijaya L., Ooi E.E., Low J.G.-H., Vasudevan S.G.
Other Authors: DUKE-NUS MEDICAL SCHOOL
Format: Article
Published: Public Library of Science (PLoS) 2018
Online Access:http://scholarbank.nus.edu.sg/handle/10635/142666
Tags: Add Tag
No Tags, Be the first to tag this record!
Institution: National University of Singapore

Internet

http://scholarbank.nus.edu.sg/handle/10635/142666

Similar Items